Patents by Inventor Parsa Shahinpoor

Parsa Shahinpoor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11964162
    Abstract: Systems and devices for continuous heating combined with oscillatory magnetic stimulation of the ST36 acupoint and/or other acupoint(s) by noninvasive infrared heating and transcutaneous magnetic field stimulation, and applied to the treatment of several physical conditions.
    Type: Grant
    Filed: August 11, 2023
    Date of Patent: April 23, 2024
    Inventors: Jonathan M Borkum, Mohsen Shahinpoor, Parsa Shahinpoor
  • Publication number: 20120116505
    Abstract: The present invention includes an ophthalmic device and system of mounting for correcting hyperopia, myopia and presbyopia. The present invention includes a limbus ring mountable in an encircling relation to a central optic zone of a cornea on a limbus annulus surrounding the cornea. In the limbus ring defines a substantially annular toroid defining a first average diameter that is selectable and has a hydrophilic coating disposed thereon. The inner radius of the limbus ring is selectable such that, upon mounting on the limbus annulus, the limbus ring causes the limbus annulus to contract or expand thereby causing the curvature of the cornea and the eye length to increase or decrease. The mounting system of the present invention is adapted to receive a limbus ring and further adapted to selectively place the limbus ring on a limbus annulus.
    Type: Application
    Filed: January 19, 2012
    Publication date: May 10, 2012
    Inventors: Mohsen Shahinpoor, David Soltanpour, Parsa Shahinpoor
  • Patent number: 8123803
    Abstract: The present invention includes an ophthalmic device and system of mounting for correcting hyperopia and presbyopia. The present invention includes a limbus ring mountable in an encircling relation to a central optic zone of a cornea on a limbus annulus surrounding the cornea. In the limbus ring defines a substantially annular toroid defining a first average diameter that is selectable and has a hydrophilic coating disposed thereon. The inner radius of the limbus ring is selectable such that, upon mounting on the limbus annulus, the limbus ring causes the limbus annulus to contract thereby causing the curvature of the cornea and the eye length to increase. The mounting system of the present invention is adapted to receive a limbus ring and further adapted to selectively place the limbus ring on a limbus annulus.
    Type: Grant
    Filed: January 24, 2007
    Date of Patent: February 28, 2012
    Inventors: Mohsen Shaninpoor, David Soltanpour, Parsa Shahinpoor
  • Publication number: 20080177383
    Abstract: The present invention includes an ophthalmic device and system of mounting for correcting hyperopia and presbyopia. The present invention includes a limbus ring mountable in an encircling relation to a central optic zone of a cornea on a limbus annulus surrounding the cornea. In the limbus ring defines a substantially annular toroid defining a first average diameter that is selectable and has a hydrophilic coating disposed thereon. The inner radius of the limbus ring is selectable such that, upon mounting on the limbus annulus, the limbus ring causes the limbus annulus to contract thereby causing the curvature of the cornea and the eye length to increase. The mounting system of the present invention is adapted to receive a limbus ring and further adapted to selectively place the limbus ring on a limbus annulus.
    Type: Application
    Filed: January 24, 2007
    Publication date: July 24, 2008
    Inventors: Mohsen Shahinpoor, David Soltanpour, Parsa Shahinpoor
  • Patent number: 7090696
    Abstract: Correction of eye refractive errors like presbyopia, hyperopia, myopia, and astigmatism using either pre-tensioned or transcutaneously energized artificial muscle implants to change the axial length and anterior curvatures of the eye globe by bringing the retina/macula region to coincide with the focal point. The implants are scleral constrictor bands, segments or ribs for inducing accommodation of a few diopters, to correct refractive errors on demand or automatically. The implant comprises an active sphinctering band encircling the sclera, implanted under the conjunctiva and under the extraocular muscles to uniformly constrict the eye globe, to induce active temporary myopia (hyperopia) by increasing(decreasing) the length and curvature of the globe. Multiple and specially designed constrictor bands enable surgeons to correct astigmatism.
    Type: Grant
    Filed: January 16, 2003
    Date of Patent: August 15, 2006
    Assignee: Environmental Robots, Inc.
    Inventors: Mohsen Shahinpoor, Parsa Shahinpoor, David Soltanpour
  • Publication number: 20060167422
    Abstract: Discussed is a method and apparatus of correcting retinal detachments by heat-shrinking a specially designed scleral band equipped with a snap-on custom-made buckle for scleral indentation over the retinal tear region. The heat shrink band is made from a heat shrink material such as a polymer or an alloy and is equipped with a custom-made buckle to perfectly fit the topological geometry of the retinal detachment region over the underlying choroid and the sclera, the conjunctiva and within the Tenon's space wherein the band is heat shrunk to create a perfect buckle over the retinal tear region to reattach the retina to the choroid and cause absorption of the subretinal fluid. Conventional, laser, microwave, Joule or radio-frequency (RF) heating means are also discussed.
    Type: Application
    Filed: December 30, 2003
    Publication date: July 27, 2006
    Inventors: Mohsen Shahinpoor, David Soltanpour, Parsa Shahinpoor
  • Publication number: 20050033210
    Abstract: Specially designed soft contact patch for treating amblyopia (lazy eye) in children and possibly adults is disclosed. A soft contact patch designed such that its pupil section is opaque and essentially black or tinted dark and its iris section surrounding the pupil section is large enough to snugly fit the eye under the eyelid and is either transparent or colored to show or match the natural color of the eye, and it is perforated and porous to allow oxygenating the iris and the sclera, so that for selected portions of time the stronger eye may be occluded. Thus, the stronger eye can be occluded for a desirable period of time to force the weaker amblyopic eye to work harder and become stronger in time to correct amblyopia.
    Type: Application
    Filed: August 7, 2003
    Publication date: February 10, 2005
    Inventor: Parsa Shahinpoor
  • Publication number: 20030139808
    Abstract: Correction of eye refractive errors such as presbyopia, hyperopia, myopia, and astigmatism by using either pre-tensioned or transcutaneously energized artificial muscle implants to change the axial length and the anterior curvatures of the eye globe by bringing the retina/macula region to coincide with the focal point. The implants are scleral constrictor bands, segments or ribs for inducing accommodation of a few diopters, to correct the refractive errors on demand or automatically. The implant comprises an active sphinctering band encircling the sclera, implanted under the conjunctiva and under the extraocular muscles to uniformly constrict the eye globe, to induce active temporary myopia (hyperopia) by increasing(decreasing) the length and curvature of the globe. Multiple and specially designed constrictor bands enable surgeons to correct astigmatism.
    Type: Application
    Filed: January 16, 2003
    Publication date: July 24, 2003
    Inventors: Mohsen Shahinpoor, Parsa Shahinpoor, David Soltanpour
  • Patent number: 6511508
    Abstract: Surgical correction of human eye refractive errors such as presbyopia, hyperopia, myopia, and stigmatism by using transcutaneously inductively energized artificial muscle implants to either actively change the axial length and the anterior curvatures of the eye globe. This brings the retina/macula region to coincide with the focal point. The implants use transcutaneously inductively energized scleral constrictor bands equipped with composite artificial muscle structures. The implants can induce enough accommodation of a few diopters, to correct presbyopia, hyperopia, and myopia on demand. In the preferred embodiment, the implant comprises an active sphinctering smart band to encircle the sclera, preferably implanted under the conjunctiva and under the extraocular muscles to uniformly constrict the eye globe, similar to a scleral buckle band for surgical correction of retinal detachment, to induce active temporary myopia (hyperopia) by increasing (decreasing) the active length of the globe.
    Type: Grant
    Filed: August 4, 2000
    Date of Patent: January 28, 2003
    Assignee: Environmental Robots, Inc.
    Inventors: Mohsen Shahinpoor, Parsa Shahinpoor, David Soltanpour
  • Publication number: 20020182162
    Abstract: A new topical drug for enhancing hair growth or diminishing hair loss or alopecia, which comprises a mixture of a nitric oxide (NO) donor such as nitrovasodilators like minoxidil (RogaineRTM), nitroglycerin, L-arginine, isosorbide dinitrate, or nitroprusside, and a cyclic guanosine 3′,5′-monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5) inhibitor such as sildenafil citrate (ViagraRTM) in a dermatologically acceptable solution mix. In this manner there will be increased vascular circulation and blood circulation to the hair bulbs and follicles and the effect of the combined compounds is enhanced synergistically.
    Type: Application
    Filed: August 7, 2002
    Publication date: December 5, 2002
    Inventors: Mohsen Shahinpoor, David Soltanpour, Parsa Shahinpoor
  • Publication number: 20020168424
    Abstract: A new topical drug (ointment or eye drop) for treating glaucoma or ocular hypertension in a patient, which comprises a mixture of a nitric oxide (NO) donor such as nitrovasodilators like minoxidil, nitroglycerin, L-arginine, isosorbide dinitrate, or nitroprusside, and a cyclic guanosine 3′,5′-monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5) inhibitor such as sildenafil citrate (ViagraRTM) in an ophthalmologically acceptable solution mix. In this manner there will be increased blood circulation to the optic nerve and the ocular hypotensive effect of the combined compounds is enhanced synergistically.
    Type: Application
    Filed: July 31, 2002
    Publication date: November 14, 2002
    Applicant: Dr. Mohsen Shahinpoor
    Inventors: Mohsen Shahinpoor, David Soltanpour, Parsa Shahinpoor